|
BioLineRx's EDP-14, for Treatment of Severe and Persistent Asthma, to Enter …
PharmaLive (press release) (subscription) BL-9010, a novel bi-specific antibody treatment for severe and persistent asthma, targets and links together two immunological modulators – IgE and CD300a. Allergen-bound IgE activates cells involved in allergic responses, such as mast cells, while … |
View full post on asthma – Google News